Cédric Cleyrat is a cellular and molecular biologist with deep expertise in protein signaling, genome engineering, and cell therapy technology innovation and development. At Bristol Myers Squibb, he leads BioEngineering & Technology Innovation, driving advances in cellular engineering, delivery systems, and process technology for next-generation cell therapies for both ex vivo (autologous and allogeneic) and in vivo non-viral applications.